What are the predictive tools in breast cancer, how do you classified them?

What are the predictive tools in breast cancer, how do you classified them?

Joseph GLIGOROV
oncologist, Paris, France
CONTINUE READING
What is the significance of HER2 amplification and how does it affect the use of antibody-drug conjugates (ADCs)?

What is the significance of HER2 amplification and how does it affect the use of antibody-drug conjugates (ADCs)?

Joseph GLIGOROV
oncologist, Paris, France
CONTINUE READING
How AI will help us to better define patient populations? What for?

How AI will help us to better define patient populations? What for?

Joseph GLIGOROV
oncologist, Paris, France
CONTINUE READING

Immunotherapies in Breast Cancer Treatment

Joseph GLIGOROV
CONTINUE READING

Drugs and options in BC in 2024?

Joseph GLIGOROV
CONTINUE READING

Predictive Models for Treatment Response and Adverse Events

Joseph GLIGOROV
CONTINUE READING

Update on adjuvant treatment in HER2+ BC.

Joseph GLIGOROV
CONTINUE READING

Thoughts on DESTINY-Breast04 for HER2-low metastatic breast cancer.

Joseph GLIGOROV
Oncologist, Paris, France
CONTINUE READING

Copyright © 2025 - BCU